K-MET Tablets

COMPOSITION
K-MET 500 mg Tablets
Each Uncoated Sustained Release Tablet Contains:
Metformin Hydrochloride IP	500 mg

K-MET 1000 mg Tablets
Each Uncoated Sustained Release Tablet Contains:
Metformin Hydrochloride IP	1000 mg

Description

INDICATIONS
In non-obese type 2 diabetes mellitus not adequately controlled with sulphonylureas. Obese type 2 diabetes mellitus not controlled by weight reduction and dietary modification.
DOSAGE AND ADMINISTRATION
Oral: Adults: One tablet to be taken once dialy with breakfast. Maximum dose for Metformin:2 gram daily in divided doses.
HOW SUPPLIED
10 Tablets per strip.

Related products